Education
About Us
Working with TipRanks
Follow Us
Opyl Ltd. (AU:PKY)
ASX:PKY
PKY Stock Chart & Stats
AU$0.02
--
Market closed
AU$0.02
--
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.13M
Market Cap
AU$4.84M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Mar 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding302,749,050
10 Day Avg. Volume406,454
30 Day Avg. Volume1,132,050
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Opyl Ltd. News
PKY FAQ
What was Opyl Ltd.’s price range in the past 12 months?
Opyl Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is Opyl Ltd.’s market cap?
Opyl Ltd.’s market cap is AU$4.84M.
When is Opyl Ltd.’s upcoming earnings report date?
Opyl Ltd.’s upcoming earnings report date is Mar 02, 2026 which is in 77 days.
How were Opyl Ltd.’s earnings last quarter?
Currently, no data Available
Is Opyl Ltd. overvalued?
According to Wall Street analysts Opyl Ltd.’s price is currently Overvalued.
Does Opyl Ltd. pay dividends?
Opyl Ltd. does not currently pay dividends.
What is Opyl Ltd.’s EPS estimate?
Opyl Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Opyl Ltd. have?
Opyl Ltd. has 302,749,050 shares outstanding.
What happened to Opyl Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Opyl Ltd.?
Currently, no hedge funds are holding shares in AU:PKY
Opyl Ltd. Stock Smart Score
Company Description
Opyl Ltd.
Opyl Ltd. (OPL) is an Australian technology company that specializes in improving clinical trials and healthcare outcomes through the use of artificial intelligence and digital tools. The company operates within the biotechnology and healthcare sectors, offering services that leverage data analytics to enhance the efficiency and success rates of clinical trials, as well as digital marketing and insights services tailored for healthcare organizations.
Technical Analysis
Global Health Limited
―
MedAdvisor Limited
―
Singular Health Group Ltd
―
HitIQ Limited
―
InteliCare Holdings Limited
―